Five new therapies or just one new treatment? A critical look at immune checkpoint inhibition in urothelial cancer

Immunotherapy. 2017 Sep;9(10):781-784. doi: 10.2217/imt-2017-0073.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • B7-H1 Antigen / antagonists & inhibitors
  • B7-H1 Antigen / immunology*
  • Biomarkers, Pharmacological
  • Humans
  • Immunotherapy / trends*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor / immunology*
  • Urologic Neoplasms / immunology
  • Urologic Neoplasms / therapy*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • B7-H1 Antigen
  • Biomarkers, Pharmacological
  • CD274 protein, human
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor